Raloxifene
Examples
Raloxifene is taken in pill form every day. It can be taken at any
time during the day. It is used only for
postmenopausal women.
How It Works
Raloxifene is a selective estrogen receptor modulator (SERM), which
works like estrogen on bone. It also works like an "anti-estrogen" on breast
tissue and the uterus.1 As a result,
raloxifene:
- Prevents and treats
osteoporosis by slowing bone thinning and causing some
increase in bone thickness.
- Lowers the risk of breast
cancer.
Compared to estrogen therapy (used to protect the bones) or
tamoxifen (used to treat cancer), raloxifene is less likely to cause uterine
cancer.
Why It Is Used
Raloxifene is used to prevent and treat osteoporosis in
women.
Raloxifene can also be used to help prevent breast cancer in women
who have a high risk for breast cancer.2
How Well It Works
Bone. Studies show that raloxifene increases
bone mineral density in the bones of the spine and neck. This lowers the risk
for broken spinal bones.3 Although raloxifene works
much like estrogen, it may not be as effective on bone.
Breast cancer. Among high-risk women,
raloxifene lowers the risk of breast cancer about as much as tamoxifen
does.2
Side Effects
Side effects of raloxifene include:
- Hot flashes.
- Vaginal
dryness.
- Leg cramps.
- Blood clots in deep veins (deep
vein thrombosis). You may or may not have symptoms of deep vein
thrombosis. Symptoms that occur in the legs include:
- Swelling.
- Warmth.
- Pain or tenderness.
- Redness.
Sometimes life-threatening
pulmonary embolism is the first sign that you have
deep vein thrombosis. Pulmonary embolism is the sudden blockage of an artery in
the lung. Blood clots in the deep veins of the leg are the most common cause of
pulmonary embolism. Symptoms of pulmonary embolism include:
- Sudden shortness of
breath.
- Chest pain that may get worse with a deep breath.
- A cough that may bring up blood.
- A fast heart rate.
- Uterine cancer (rare).
Less serious side effects include:
- Muscle and joint aches.
- Weight
gain.
- Rash.
See Drug Reference for a full list of side effects. (Drug Reference
is not available in all systems.)
What To Think About
Raloxifene raises your risk of dangerous blood clots. So does bed
rest. If you plan to have a surgery followed by bed rest, stop taking
raloxifene at least 3 days before the surgery. This will lower your risk of
blood clots.
Raloxifene should not be used in women
who:
- Are pregnant or might become pregnant. If you
are nursing, do not take raloxifene, because experts do not know if the drug
passes through breast milk.
- Have a history of blood clots in their
deep veins (venous thromboembolism, deep vein thrombosis, or
pulmonary embolism).
- Are taking certain
medicines, such as cholestyramine, to lower the amounts of cholesterol in the
blood.
- Have liver disease.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.
References
Citations
-
Abramowicz M (2006). Raloxifene (Evista) for breast
cancer prevention in postmenopausal women. Medical Letter on
Drugs and Therapeutics, 48(1234): 37.
-
Vogel VG, et al. (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NASBP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA, 295(23): 2727–2741.
-
Drugs for prevention and treatment of postmenopausal
osteoporosis (2005). Treatment Guidelines From the Medical
Letter, 3(38): 69–74.
|
|
| Author: | Robin Parks, MS | Last Updated: December 1, 2006 |
| Medical Review: | Joy Melnikow, MD, MPH - Family Medicine
Carla J. Herman, MD, MPH - Internal Medicine |
|
|
|
© 1995-2008, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
|
|